Algert Global LLC Amarin Corp Plcuk Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
A detailed history of Algert Global LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Algert Global LLC holds 14,970 shares of AMRN stock, worth $9,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,970
Previous 27,436
45.44%
Holding current value
$9,131
Previous $17,000
58.82%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMRN
# of Institutions
181Shares Held
68.6MCall Options Held
192KPut Options Held
78.1K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.69 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.51 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...